The Trump administration has initiated a large-scale workforce reduction across two major federal health agencies, with approximately 5,200 employees at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC set to be laid off in the coming months. The decision follows an internal review aimed at streamlining operations and reducing costs within public health agencies.
According to officials familiar with the restructuring plan, the layoffs will affect a wide range of positions, including research scientists, administrative staff, and policy analysts. The move comes as part of an effort to reorganize federal health agencies following widespread criticism of their handling of the COVID-19 pandemic and other public health crises.
Health and Human Services (HHS) Secretary Xavier Becerra defended the decision, stating that the agencies must adapt to new public health priorities while ensuring efficient use of taxpayer funds. He emphasized that the restructuring is not a reflection of poor performance by employees but rather an effort to modernize public health operations in response to evolving challenges.
The layoffs have sparked concern among public health advocates, who warn that reducing personnel could weaken the nation’s preparedness for future health emergencies. Some experts argue that cutting resources at agencies responsible for disease prevention and medical research could have long-term consequences.
The affected employees are expected to receive severance packages, and some may be reassigned to other federal agencies or given opportunities in state health departments. However, uncertainty remains about how these reductions will impact ongoing research initiatives and public health programs.
As the layoffs move forward, lawmakers are expected to hold hearings to examine the broader implications of the decision and explore potential alternatives to downsizing the nation’s top health agencies.